Rectal colonization with vancomycin-resistant enterococci among high-risk patients in an Israeli hospital

被引:17
作者
Dan, M [1 ]
Poch, F
Leibson, L
Smetana, S
Priel, I
机构
[1] E Wolfson Hosp, Infect Dis Unit, IL-58100 Holon, Israel
[2] E Wolfson Hosp, Nephrol Unit, IL-58100 Holon, Israel
[3] E Wolfson Hosp, Dept Pulm Med, IL-58100 Holon, Israel
关键词
vancomycin-resistant enterococci; rectal colonization; intensive care unit; renal dialysis;
D O I
10.1053/jhin.1998.0641
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The prevalence of rectal carriage of vancomycin-resistant enteroccoci (VRE) in two high-risk populations -61 patients admitted to ICU and 92 patients on renal dialysis - was studied longitudinally over a period of six months in a 650-bed general hospital. ICU patients were swabbed weekly and dialysis patients monthly Enterococcal isolates were fully identified using the ATE identification system, and MICs were determined according to the NCCLS recommendations. Enterococci were isolated in 52 (83.6%) ICU patients and 86 (93.4%) dialysis patients. VRE were recovered at least once in 14 (27%) ICU patients and four (4.8%) dialysis patients. All VRE isolates (MIC of vancomycin greater than or equal to 256 mu g/mL) were resistant to teicoplanin (MIC greater than or equal to 32 mu g/mL; vanA phenotype), 87.5% were ampicillin-resistant, and 92% showed high-level resistance to gentamicin; 88% were E. faecium. The main risk factors for acquisition of VRE included duration of hospitalization in the six months preceding entry into the study and during the survey (P = 0.009 and 0.007 respectively, for ICU patients), and duration of antibiotic administration (P = 0.005, for ICU patients). The impact of vancomycin was most prominent (P = 0.005 for receipt and 0.06 for duration of administration, in ICU patients). Six of the 18 VRE carriers developed bacteraemia, six isolates being vancomycin-susceptible and one vancomycin-resistant (one patient had both). In this study, the first in Israel, a low rectal carriage rate occured in renal dialysis patients and antibiotic use was the most important risk factor for VRE colonization. (C) 1999 The Hospital Infection Society.
引用
收藏
页码:231 / 238
页数:8
相关论文
共 19 条
[1]   Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci [J].
Bonten, MJM ;
Hayden, MK ;
Nathan, C ;
vanVoorhis, J ;
Matushek, M ;
Slaughter, S ;
Rice, T ;
Weinstein, RA .
LANCET, 1996, 348 (9042) :1615-1619
[2]  
CDC, 1993, MMWR-MORBID MORTAL W, V42, P597
[3]  
CURRIE BP, 1996, INT J INFECT DIS, V1, P87
[4]   THE EPIDEMIOLOGY OF INTRAVENOUS VANCOMYCIN USAGE IN A UNIVERSITY HOSPITAL - A 10-YEAR STUDY [J].
ENA, J ;
DICK, RW ;
JONES, RN ;
WENZEL, RP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (05) :598-602
[5]   VANCOMYCIN-RESISTANT ENTEROCOCCI COLONIZING THE INTESTINAL TRACTS OF HOSPITALIZED-PATIENTS [J].
GORDTS, B ;
VANLANDUYT, H ;
IEVEN, M ;
VANDAMME, P ;
GOOSSENS, H .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (11) :2842-2846
[6]   NOSOCOMIAL OUTBREAK DUE TO ENTEROCOCCUS-FAECIUM HIGHLY RESISTANT TO VANCOMYCIN, PENICILLIN, AND GENTAMICIN [J].
HANDWERGER, S ;
RAUCHER, B ;
ALTARAC, D ;
MONKA, J ;
MARCHIONE, S ;
SINGH, KV ;
MURRAY, BE ;
WOLFF, J ;
WALTERS, B .
CLINICAL INFECTIOUS DISEASES, 1993, 16 (06) :750-755
[7]  
HUMAR A, 1996, 36 INT C ANT AG CHEM
[8]   Epidemiology, appropriateness, and cost of vancomycin use [J].
Jarvis, WR .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (05) :1200-1203
[9]  
JOHN JF, 1996, INFECT DIS ALERT, V12, P38
[10]   Historical yearly usage of vancomycin [J].
Kirst, HA ;
Thompson, DG ;
Nicas, TI .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) :1303-1304